Cargando…

The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL

BACKGROUND: Lp(a) and LDL-C are both risk factors of atherosclerotic cardiovascular disease (ASCVD). But there was a contradiction point in LDL-C and Lp(a) control. The appropriate level of LDL-C and Lp(a) in the prevention of ASCVD is still pending. OBJECTIVE: To investigate the correlation of Lp(a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chuang, Chen, Qiwen, Zhang, Mei, Liu, Yin, Chu, Yushun, Meng, Fanpeng, Wang, Jianyu, Tang, Jie, Luo, Jian, Niu, Xiulong, Wei, Maoti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816444/ https://www.ncbi.nlm.nih.gov/pubmed/33468066 http://dx.doi.org/10.1186/s12872-021-01861-6

Ejemplares similares

Particles and corrected particles of LDL and non-HDL are stronger predicters of coronary lesion in postmenopausal women
por: Li, Chuang, et al.
Publicado: (2021)

Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels <400 mg/dL
por: Moriyama, Kengo, et al.
Publicado: (2016)

Clinical implications of the log linear association between LDL-C lowering and cardiovascular risk reduction: Greatest benefits when LDL-C >100 mg/dl
por: Robinson, Jennifer G., et al.
Publicado: (2020)

LDL-C/HDL-C Ratio Predicts Carotid Intima-Media Thickness Progression Better Than HDL-C or LDL-C Alone
por: Enomoto, Mika, et al.
Publicado: (2011)

Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher
por: Ginsberg, Henry N., et al.
Publicado: (2016)

Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease
por: Packard, Chris J.
Publicado: (2022)

The Induction of Cytokine Release in Monocytes by Electronegative Low-Density Lipoprotein (LDL) Is Related to Its Higher Ceramide Content than Native LDL
por: Estruch, Montserrat, et al.
Publicado: (2013)

The LDL-C/Apo B predicts coronary atherosclerotic heart disease in non-diabetic patients without high LDL-C
por: Jung, Hae Won, et al.
Publicado: (2023)

The evaluation and management of patients with LDL-C ≥ 190 mg/dL in a large health care system
por: Jackson, Candace L., et al.
Publicado: (2020)

Oxidative modifications of foetal LDL-c and HDL-c lipoproteins in preeclampsia
por: León-Reyes, G., et al.
Publicado: (2018)

Is evaluation of non-HDL-C better than calculated LDL-C in CAD patients? MMIMSR experiences
por: Kathariya, Gobardhan, et al.
Publicado: (2020)

LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicenter Cross-Sectional Study
por: Imajo, Kento, et al.
Publicado: (2014)

KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles
por: Bari, Rafijul, et al.
Publicado: (2016)

Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
por: Albosta, Michael S, et al.
Publicado: (2023)

Effects of Serum LDL-C, CysC, and D-D in Patients with Coronary Atherosclerotic Heart Disease
por: Shen, Chaofeng, et al.
Publicado: (2022)

Contribution of Dietary Intakes of Antioxidants to Homocysteine-Induced Low Density Lipoprotein (LDL) Oxidation in Atherosclerotic Patients
por: Seo, Hongseog, et al.
Publicado: (2010)

Approaches to Visualising Endocytosis of LDL-Related Lipoproteins
por: Siddiqui, Halima, et al.
Publicado: (2022)

Lipoprotein(a) Concentrations Correlate With LDL-C in Children With Type 1 and 2 Diabetes
por: Foster, Christy, et al.
Publicado: (2021)

LDL retention time in plasma can be -based on causation- estimated by the lipid composition of LDL and other lipoproteins
por: Jansen, Martin, et al.
Publicado: (2022)

Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study
por: Komiya, Ichiro, et al.
Publicado: (2021)

Developing a Modified Low-Density Lipoprotein (M-LDL-C) Friedewald's Equation as a Substitute for Direct LDL-C Measure in a Ghanaian Population: A Comparative Study
por: Ephraim, Richard K. D., et al.
Publicado: (2018)

Triglyceride and non-HDL-C are better predictors of cardiovascular disease risk factors in Chinese Han children and adolescents than LDL-C
por: Zhu, Wei-fen, et al.
Publicado: (2013)

Predictors of Plaque Progression in Hypertensive Angina Patients with Achieved Low-Density Lipoprotein Cholesterol Less Than 70 mg/dL after Rosuvastatin Treatment
por: Hong, Young Joon, et al.
Publicado: (2015)

Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements
por: Yeang, Calvin, et al.
Publicado: (2021)

Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?
por: Clem, James R, et al.
Publicado: (2009)

Transiently Elevated TC and sdLDL-C Levels and Falsely Low LDL-C Levels in Patients with Extrahepatic Cholangiocarcinoma
por: Guo, Yi, et al.
Publicado: (2021)

Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol
por: Hirano, Tsutomu, et al.
Publicado: (2022)

Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
por: Khan, Tina Z., et al.
Publicado: (2021)

Evaluation of different formulas for LDL-C calculation
por: Vujovic, Ana, et al.
Publicado: (2010)

Evidence-based goals in LDL-C reduction
por: Soran, Handrean, et al.
Publicado: (2017)

The lack of association between different LDL‐C levels and oxidized LDL in patients with type 2 diabetes
por: Rabizadeh, Soghra, et al.
Publicado: (2023)

Non-HDL-C Is More Stable Than LDL-C in Assessing the Percent Attainment of Non-fasting Lipid for Coronary Heart Disease Patients
por: Guo, Li-Ling, et al.
Publicado: (2021)

Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agents
por: Konrad, Robert J, et al.
Publicado: (2011)

A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C
por: Liao, Fangxin, et al.
Publicado: (2015)

Mathematical Model for Low Density Lipoprotein (LDL) Endocytosis by Hepatocytes
por: Wattis, J. A. D., et al.
Publicado: (2008)

Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

The smile is stronger than the handshake
por: Fine, Lauren, et al.
Publicado: (2020)

Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation
por: Komiyama, Maki, et al.
Publicado: (2016)

Predictive value of LDL/HDL ratio in coronary atherosclerotic heart disease
por: Sun, Ting, et al.
Publicado: (2022)

Trends in LDL-C and Non-HDL-C Levels with Age
por: Zhang, Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_utkbilbr2qm5vs7j1vps8pgc4b